ethinyl estradiol; norgestimate - Profile
✉ Email this page to a colleague
What are the generic sources for ethinyl estradiol; norgestimate and what is the scope of freedom to operate?
Ethinyl estradiol; norgestimate
is the generic ingredient in nineteen branded drugs marketed by Janssen Pharms, Xiromed, Aurobindo Pharma Ltd, Novast Labs Ltd, Glenmark Pharms Ltd, Glenmark Speclt, Lupin, Lupin Pharms, Mylan, Naari Pte, Watson Labs, Ph Health, Barr, Barr Labs Inc, Novast Labs, and Aurobindo Pharma, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.Summary for ethinyl estradiol; norgestimate
| US Patents: | 0 |
| Tradenames: | 19 |
| Applicants: | 16 |
| NDAs: | 34 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ethinyl estradiol; norgestimate |
US Patents and Regulatory Information for ethinyl estradiol; norgestimate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Pharms | ORTHO CYCLEN-21 | ethinyl estradiol; norgestimate | TABLET;ORAL-21 | 019653-001 | Dec 29, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Janssen Pharms | ORTHO TRI-CYCLEN | ethinyl estradiol; norgestimate | TABLET;ORAL-21 | 019697-002 | Jul 3, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Xiromed | ESTARYLLA | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 090794-001 | Jan 30, 2013 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ethinyl estradiol; norgestimate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Janssen Pharms | ORTHO TRI-CYCLEN | ethinyl estradiol; norgestimate | TABLET;ORAL-21 | 019697-002 | Jul 3, 1992 | ⤷ Start Trial | ⤷ Start Trial |
| Janssen Pharms | ORTHO TRI-CYCLEN | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 019697-001 | Jul 3, 1992 | ⤷ Start Trial | ⤷ Start Trial |
| Janssen Pharms | ORTHO TRI-CYCLEN | ethinyl estradiol; norgestimate | TABLET;ORAL-21 | 019697-002 | Jul 3, 1992 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
